IE Biotechnology & Medical Research

Alkermes Plc (ALKS)

Track

Track

Alkermes Plc experienced significant selling activity over the past quarter, with insiders offloading over 2.2 million dollars in stock. These transactions, primarily planned sales, occurred following a strong earnings report. Despite the negative price trend, leadership remains active in liquidating holdings, reflecting a consistent pattern of divestment among key corporate officers.
Ticker: ALKS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alkermes Plc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
185.83
Quantity 67,590 +27.4%
Value US$4,268,077
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
280.86
Quantity 72,202
Value US$1,396,447
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
275.20
Quantity 43,164 -40.6%
Value US$2,840,239
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
48.01
Quantity 2,034
Value US$97,652
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
46.99
Quantity 9,000 -12.1%
Value US$422,874
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
46.99
Quantity 9,000
Value US$422,874
Nichols Christian Todd SVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
49.65
Quantity 664 -0.6%
Value US$32,969
Nichols Christian Todd SVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
49.19
Quantity 6,912 -6.3%
Value US$339,967
Nichols Christian Todd Officer Officer
Transaction date
Proposed sale
Price
49.23
Quantity 7,576
Value US$372,937
2.8
snyderman nancy lynn MD Non-Executive Director
Transaction date
Sale
Price
50.35
Quantity 44,472 -74.3%
Value US$2,239,076
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
48.58
Quantity 9,000 -11.5%
Value US$437,220
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
48.58
Quantity 2,034 -0.9%
Value US$98,812
2.8
snyderman nancy lynn MD Officer Officer
Transaction date
Proposed sale
Price
50.35
Quantity 44,472
Value US$2,239,076
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
48.58
Quantity 2,034
Value US$98,812
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
48.58
Quantity 9,000
Value US$437,220
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
54.03
Quantity 2,034 -0.9%
Value US$109,897
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
54.03
Quantity 2,034
Value US$109,897
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
52.13
Quantity 700 -0.9%
Value US$36,492
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
51.46
Quantity 8,300 -10.1%
Value US$427,129
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
51.51
Quantity 9,000
Value US$463,621
Wright Christopher I Non-Executive Director
Transaction date
Planned sale
Price
45.10
Quantity 2,000 -7.2%
Value US$90,200
Wright Christopher I Officer Officer
Transaction date
Proposed sale
Price
45.10
Quantity 2,000
Value US$90,200
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
43.05
Quantity 2,034 -0.9%
Value US$87,564
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
43.05
Quantity 2,034 -0.9%
Value US$87,564
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
43.05
Quantity 2,034
Value US$87,564
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
41.67
Quantity 9,000 -10.4%
Value US$375,044
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
41.67
Quantity 9,000
Value US$375,043
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
41.67
Quantity 9,000
Value US$375,043
2.1
Parisi Samuel Joseph VP, Finance (Interim PAO) Officer
Transaction date
Sale
Price
42.36
Quantity 16,217 -67.8%
Value US$687,007
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
33.20
Quantity 2,034 -0.9%
Value US$67,529
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
33.20
Quantity 2,034
Value US$67,529
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
33.40
Quantity 9,000 -10.0%
Value US$300,560
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
33.40
Quantity 9,000
Value US$300,560
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
34.57
Quantity 2,034 -0.9%
Value US$70,315
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
34.57
Quantity 2,034
Value US$70,315
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
35.51
Quantity 9,000 -9.5%
Value US$319,604
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
35.51
Quantity 9,000
Value US$319,604
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
29.76
Quantity 2,034 -0.9%
Value US$60,532
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
29.76
Quantity 2,034
Value US$60,532
2.1
Parisi Samuel Joseph VP, Finance (Interim PAO) Officer
Transaction date
Planned sale
Price
29.29
Quantity 6,890 -47.2%
Value US$201,808
Nichols Christian Todd SVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 6,000 -5.2%
Value US$180,000
Gaffin David Joseph EVP, CLO, Alkermes, Inc. Officer
Transaction date
Planned sale
Price
29.29
Quantity 2,034 -0.8%
Value US$59,576
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
29.72
Quantity 9,000 -9.1%
Value US$267,485
Nichols Christian Todd Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 6,000
Value US$180,000
Gaffin David Joseph Officer Officer
Transaction date
Proposed sale
Price
29.29
Quantity 2,034
Value US$59,576
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
29.72
Quantity 9,000
Value US$267,485
3.3
Cooke Shane Officer Officer
Transaction date
Proposed sale
Price
34.57
Quantity 61,200
Value US$2,115,674
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
33.93
Quantity 9,000
Value US$305,384
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
33.54
Quantity 4,000 -6.5%
Value US$134,160
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
34.24
Quantity 5,000 -7.5%
Value US$171,224
3.3
Cooke Shane Non-Executive Director
Transaction date
Planned sale
Price
34.78
Quantity 32,113 -23.6%
Value US$1,116,877
3.3
Cooke Shane Non-Executive Director
Transaction date
Planned sale
Price
34.34
Quantity 29,087 -17.6%
Value US$998,795
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 5,000
Value US$150,005
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 5,000 -7.5%
Value US$150,005
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
28.00
Quantity 4,000
Value US$112,000
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
28.00
Quantity 4,000 -6.1%
Value US$112,000
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 3,748 -5.4%
Value US$112,447
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 3,748
Value US$112,447
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
29.30
Quantity 4,000
Value US$117,200
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
29.30
Quantity 4,000 -5.7%
Value US$117,200
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
30.38
Quantity 9,000
Value US$273,442
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.38
Quantity 9,000 -11.4%
Value US$273,442
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
31.53
Quantity 9,000
Value US$283,777
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
31.53
Quantity 9,000 -10.9%
Value US$283,776
Nichols Christian Todd Officer Officer
Transaction date
Proposed sale
Price
31.09
Quantity 3,334
Value US$103,654
Nichols Christian Todd SVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
31.09
Quantity 3,334 -3.7%
Value US$103,654
Nichols Christian Todd SVP, Chief Commercial Officer Officer
Transaction date
Planned sale
Price
31.95
Quantity 3,333 -3.6%
Value US$106,489
Nichols Christian Todd Officer Officer
Transaction date
Proposed sale
Price
31.95
Quantity 3,333
Value US$106,489
2.1
Parisi Samuel Joseph VP, Finance (Interim PAO) Officer
Transaction date
Planned sale
Price
34.00
Quantity 1,938 -20.1%
Value US$65,892
2.1
Parisi Samuel Joseph VP, Finance (Interim PAO) Officer
Transaction date
Planned sale
Price
35.26
Quantity 3,743 -32.7%
Value US$131,978
2.1
Parisi Samuel Joseph VP, Finance (Interim PAO) Officer
Transaction date
Planned sale
Price
35.69
Quantity 1,327 -14.7%
Value US$47,361
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
36.02
Quantity 108,833 -65.3%
Value US$3,920,001
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
34.02
Quantity 35,586 -17.6%
Value US$1,210,696
Hopkinson Craig C. Officer Officer
Transaction date
Proposed sale
Price
35.53
Quantity 144,419
Value US$5,130,694
Hopkinson Craig C. EVP R&D, Chief Medical Officer Officer
Transaction date
Planned sale
Price
33.27
Quantity 33,108 -36.4%
Value US$1,101,470
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-02 2026-10-02 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
67,590 +27.4%
185.83
US$4,268,077 		67,590 +27.4% 185.83 US$4,268,077
2026-10-02 2026-10-02 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
72,202
280.86
US$1,396,447 		72,202 280.86 US$1,396,447
2026-09-03 2026-09-03 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
43,164 -40.6%
275.20
US$2,840,239 		43,164 -40.6% 275.20 US$2,840,239
2026-09-03 2026-09-03 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
2,034
48.01
US$97,652 		2,034 48.01 US$97,652
2026-09-01 2026-09-01 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
9,000 -12.1%
46.99
US$422,874 		9,000 -12.1% 46.99 US$422,874
2026-09-01 2026-09-01 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
46.99
US$422,874 		9,000 46.99 US$422,874
2026-08-17 2026-08-17 PlS Planned sale
Nichols Christian Todd

SVP, Chief Commercial Officer

Officer
664 -0.6%
49.65
US$32,969 		664 -0.6% 49.65 US$32,969
2026-08-17 2026-08-17 PlS Planned sale
Nichols Christian Todd

SVP, Chief Commercial Officer

Officer
6,912 -6.3%
49.19
US$339,967 		6,912 -6.3% 49.19 US$339,967
2026-08-17 2026-08-17 PrS Proposed sale
Nichols Christian Todd

Officer

Officer
7,576
49.23
US$372,937 		7,576 49.23 US$372,937
2026-08-03 2026-08-03 S Sale
2.8
snyderman nancy lynn MD
Non-Executive Director
44,472 -74.3%
50.35
US$2,239,076 		44,472 -74.3% 50.35 US$2,239,076
2026-08-03 2026-08-03 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
9,000 -11.5%
48.58
US$437,220 		9,000 -11.5% 48.58 US$437,220
2026-08-03 2026-08-03 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
2,034 -0.9%
48.58
US$98,812 		2,034 -0.9% 48.58 US$98,812
2026-08-03 2026-08-03 PrS Proposed sale
2.8
snyderman nancy lynn MD

Officer

Officer
44,472
50.35
US$2,239,076 		44,472 50.35 US$2,239,076
2026-08-03 2026-08-03 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
2,034
48.58
US$98,812 		2,034 48.58 US$98,812
2026-08-03 2026-08-03 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
48.58
US$437,220 		9,000 48.58 US$437,220
2026-07-06 2026-07-06 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
2,034 -0.9%
54.03
US$109,897 		2,034 -0.9% 54.03 US$109,897
2026-07-06 2026-07-06 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
2,034
54.03
US$109,897 		2,034 54.03 US$109,897
2026-07-01 2026-07-01 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
700 -0.9%
52.13
US$36,492 		700 -0.9% 52.13 US$36,492
2026-07-01 2026-07-01 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
8,300 -10.1%
51.46
US$427,129 		8,300 -10.1% 51.46 US$427,129
2026-07-01 2026-07-01 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
51.51
US$463,621 		9,000 51.51 US$463,621
2026-06-12 2026-06-12 PlS Planned sale
Wright Christopher I
Non-Executive Director
2,000 -7.2%
45.10
US$90,200 		2,000 -7.2% 45.10 US$90,200
2026-06-12 2026-06-12 PrS Proposed sale
Wright Christopher I

Officer

Officer
2,000
45.10
US$90,200 		2,000 45.10 US$90,200
2026-06-04 2026-06-04 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
2,034 -0.9%
43.05
US$87,564 		2,034 -0.9% 43.05 US$87,564
2026-06-04 2026-06-04 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
2,034 -0.9%
43.05
US$87,564 		2,034 -0.9% 43.05 US$87,564
2026-06-04 2026-06-04 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
2,034
43.05
US$87,564 		2,034 43.05 US$87,564
2026-06-01 2026-06-01 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
9,000 -10.4%
41.67
US$375,044 		9,000 -10.4% 41.67 US$375,044
2026-06-01 2026-06-01 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
41.67
US$375,043 		9,000 41.67 US$375,043
2026-06-01 2026-06-01 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
41.67
US$375,043 		9,000 41.67 US$375,043
2026-05-29 2026-05-29 S Sale
2.1
Parisi Samuel Joseph

VP, Finance (Interim PAO)

Officer
16,217 -67.8%
42.36
US$687,007 		16,217 -67.8% 42.36 US$687,007
2026-05-04 2026-05-04 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
2,034 -0.9%
33.20
US$67,529 		2,034 -0.9% 33.20 US$67,529
2026-05-04 2026-05-04 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
2,034
33.20
US$67,529 		2,034 33.20 US$67,529
2026-05-01 2026-05-01 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
9,000 -10.0%
33.40
US$300,560 		9,000 -10.0% 33.40 US$300,560
2026-05-01 2026-05-01 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
33.40
US$300,560 		9,000 33.40 US$300,560
2026-04-06 2026-04-06 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
2,034 -0.9%
34.57
US$70,315 		2,034 -0.9% 34.57 US$70,315
2026-04-06 2026-04-06 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
2,034
34.57
US$70,315 		2,034 34.57 US$70,315
2026-04-01 2026-04-01 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
9,000 -9.5%
35.51
US$319,604 		9,000 -9.5% 35.51 US$319,604
2026-04-01 2026-04-01 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
35.51
US$319,604 		9,000 35.51 US$319,604
2026-03-04 2026-03-03 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
2,034 -0.9%
29.76
US$60,532 		2,034 -0.9% 29.76 US$60,532
2026-03-03 2026-03-03 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
2,034
29.76
US$60,532 		2,034 29.76 US$60,532
2026-03-04 2026-03-02 PlS Planned sale
2.1
Parisi Samuel Joseph

VP, Finance (Interim PAO)

Officer
6,890 -47.2%
29.29
US$201,808 		6,890 -47.2% 29.29 US$201,808
2026-03-04 2026-03-02 PlS Planned sale
Nichols Christian Todd

SVP, Chief Commercial Officer

Officer
6,000 -5.2%
30.00
US$180,000 		6,000 -5.2% 30.00 US$180,000
2026-03-04 2026-03-02 PlS Planned sale
Gaffin David Joseph

EVP, CLO, Alkermes, Inc.

Officer
2,034 -0.8%
29.29
US$59,576 		2,034 -0.8% 29.29 US$59,576
2026-03-04 2026-03-02 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
9,000 -9.1%
29.72
US$267,485 		9,000 -9.1% 29.72 US$267,485
2026-03-02 2026-03-02 PrS Proposed sale
Nichols Christian Todd

Officer

Officer
6,000
30.00
US$180,000 		6,000 30.00 US$180,000
2026-03-02 2026-03-02 PrS Proposed sale
Gaffin David Joseph

Officer

Officer
2,034
29.29
US$59,576 		2,034 29.29 US$59,576
2026-03-02 2026-03-02 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
29.72
US$267,485 		9,000 29.72 US$267,485
2026-02-02 2026-02-02 PrS Proposed sale
3.3
Cooke Shane

Officer

Officer
61,200
34.57
US$2,115,674 		61,200 34.57 US$2,115,674
2026-02-02 2026-02-02 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
33.93
US$305,384 		9,000 33.93 US$305,384
2026-02-02 2026-02-02 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
4,000 -6.5%
33.54
US$134,160 		4,000 -6.5% 33.54 US$134,160
2026-02-02 2026-02-02 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
5,000 -7.5%
34.24
US$171,224 		5,000 -7.5% 34.24 US$171,224
2026-02-02 2026-02-02 PlS Planned sale
3.3
Cooke Shane
Non-Executive Director
32,113 -23.6%
34.78
US$1,116,877 		32,113 -23.6% 34.78 US$1,116,877
2026-02-02 2026-02-02 PlS Planned sale
3.3
Cooke Shane
Non-Executive Director
29,087 -17.6%
34.34
US$998,795 		29,087 -17.6% 34.34 US$998,795
2026-01-08 2026-01-08 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
5,000
30.00
US$150,005 		5,000 30.00 US$150,005
2026-01-08 2026-01-08 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
5,000 -7.5%
30.00
US$150,005 		5,000 -7.5% 30.00 US$150,005
2026-01-02 2026-01-02 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
4,000
28.00
US$112,000 		4,000 28.00 US$112,000
2026-01-02 2026-01-02 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
4,000 -6.1%
28.00
US$112,000 		4,000 -6.1% 28.00 US$112,000
2025-12-05 2025-12-03 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
3,748 -5.4%
30.00
US$112,447 		3,748 -5.4% 30.00 US$112,447
2025-12-03 2025-12-03 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
3,748
30.00
US$112,447 		3,748 30.00 US$112,447
2025-12-01 2025-12-01 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
4,000
29.30
US$117,200 		4,000 29.30 US$117,200
2025-12-01 2025-12-01 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
4,000 -5.7%
29.30
US$117,200 		4,000 -5.7% 29.30 US$117,200
2025-11-03 2025-11-03 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
30.38
US$273,442 		9,000 30.38 US$273,442
2025-11-03 2025-11-03 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
9,000 -11.4%
30.38
US$273,442 		9,000 -11.4% 30.38 US$273,442
2025-10-15 2025-10-15 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
9,000
31.53
US$283,777 		9,000 31.53 US$283,777
2025-10-15 2025-10-15 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
9,000 -10.9%
31.53
US$283,776 		9,000 -10.9% 31.53 US$283,776
2025-06-10 2025-06-10 PrS Proposed sale
Nichols Christian Todd

Officer

Officer
3,334
31.09
US$103,654 		3,334 31.09 US$103,654
2025-06-10 2025-06-10 PlS Planned sale
Nichols Christian Todd

SVP, Chief Commercial Officer

Officer
3,334 -3.7%
31.09
US$103,654 		3,334 -3.7% 31.09 US$103,654
2025-06-10 2025-06-09 PlS Planned sale
Nichols Christian Todd

SVP, Chief Commercial Officer

Officer
3,333 -3.6%
31.95
US$106,489 		3,333 -3.6% 31.95 US$106,489
2025-06-09 2025-06-09 PrS Proposed sale
Nichols Christian Todd

Officer

Officer
3,333
31.95
US$106,489 		3,333 31.95 US$106,489
2025-02-28 2025-02-28 PlS Planned sale
2.1
Parisi Samuel Joseph

VP, Finance (Interim PAO)

Officer
1,938 -20.1%
34.00
US$65,892 		1,938 -20.1% 34.00 US$65,892
2025-02-25 2025-02-25 PlS Planned sale
2.1
Parisi Samuel Joseph

VP, Finance (Interim PAO)

Officer
3,743 -32.7%
35.26
US$131,978 		3,743 -32.7% 35.26 US$131,978
2025-02-20 2025-02-20 PlS Planned sale
2.1
Parisi Samuel Joseph

VP, Finance (Interim PAO)

Officer
1,327 -14.7%
35.69
US$47,361 		1,327 -14.7% 35.69 US$47,361
2025-02-14 2025-02-13 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
108,833 -65.3%
36.02
US$3,920,001 		108,833 -65.3% 36.02 US$3,920,001
2025-02-14 2025-02-13 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
35,586 -17.6%
34.02
US$1,210,696 		35,586 -17.6% 34.02 US$1,210,696
2025-02-13 2025-02-13 PrS Proposed sale
Hopkinson Craig C.

Officer

Officer
144,419
35.53
US$5,130,694 		144,419 35.53 US$5,130,694
2025-02-14 2025-02-12 PlS Planned sale
Hopkinson Craig C.

EVP R&D, Chief Medical Officer

Officer
33,108 -36.4%
33.27
US$1,101,470 		33,108 -36.4% 33.27 US$1,101,470
Explore more

More insider trading research around Alkermes Plc

More insider trades in IE
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity